The impact of the COVID-19 pandemic on hospital-acquired infections at a comprehensive cancer center

ABSTRACT

Robust infection control (IC) measures were deployed across healthcare institutions at the start of the COVID-19 pandemic, resulting in increased use of personal protective equipment (PPE), enhanced contact precautions, and emphasis on hand hygiene. The impact of these IC measures on the rates of hospital-acquired infections (HAIs), such as multidrug-resistant organisms (MDROs), device- related infections (DRIs), Clostridium difficile infection (CDI), and respiratory viral infections (RVIs) is not known. Here, we evaluated the effect of the enhanced IC practices on the occurrence of HAIs in a comprehensive cancer center. We analyzed the monthly HAIs rates from September 2017 through March 2022, including data 42 months pre-pandemic and 24 months during the pandemic. The incidence rate ratios (IRR) were calculated for all HAIs. When comparing pre-pandemic to the pandemic period, a significant increase in the overall incidence rate (IR) of MDROs from 0.56 to 0.67 per 1,000 patient days with an IRR of 1.19 (95% CI 1.02- 1.39), a decrease in the IR of CLABSIs and a stable IR of CAUTIs and VAEs were observed. A significant decrease was observed in the IR of CDI (IRR 0.65 (95% CI 0.55-0.78)). The total IR of hospitalacquired RVIs per 1,000 admissions (5.24 to 1.82;IRR 0.36;95% CI 0.30-0.44) decreased. Implementing strict IC measures during the COVID-19 pandemic in a cancer hospital led to a significant decrease in many HAIs and a reduction in nosocomial RVIs. However, whether these enhanced measures are needed during the upcoming respiratory viral seasons is not known.